Prostate Cancer Risk Calculator

Dr. n. med. Roman Sosnowski

Centrum Onkologii, Warszawa

PSA – ideal marker?

• With increase of the PSA cut-off – the number of unnecessary biopsies will decrease – the number of cancers missed will increase

M. Roobol, Probabilities based on Risk calculator level 2

The ideal prostate cancer risk calculator

• Has the capability to avoid unnecessary biopsies

• To increase detection of potentially aggressive prostate cancer

Heidi A. van Vugt et all., BJU INT. 2011,110, 180–187

European Journal of Cancer(2012)48, 1809–1815

ERSPC prostate cancer risk calculator - on the basis of 6288 men screened within the Dutch part of the European Randomized study of Screening for Prostate Cancer (ERSPC)

www.kalkulatorprostaty.pl

Case presentation

businessmen lawyer artist

Case 1

• 70-years old businessmen

• Moderate LUTS

• DRE - BPH

• Prostate volume estimated by DRE: 30-40 ml

• PSA – 4 ng/ml

Case 1

• DRE - BPH

• Prostate volume estimated by DRE: 30-40 ml

• PSA – 4 ng/ml

Case 2

• 60-years old, lawyer

• LUTS which decrees QoL

• PSA – 4,00 ng/ml

• DRE – BPE!

• Prostate volume estimated by DRE: 50-60 ml

Case 2

• PSA – 4,00 ng/ml

• DRE – BPO!

• Prostate volume estimated by DRE: 50-60 ml

Case 3

• 60-years old, artist

• Moderate LUTS

• PSA – 2,5 ng/ml

• DRE: BPH

• Prostate volume estimated by DRE: 40 ml

Case 3

• PSA – 2,5 ng/ml

• DRE: BPH

• Prostate volume estimated by DRE: 40 ml

Case 3

Case presentation

businessmen small prostate PSA 4,00 Risk of PCa – 33% (9%)

lawyer big prostate PSA 4,00 Risk of PCa – 7% (1%)

artist midle prostate PSA 2,00 Risk of PCa – 6% (1%)

Other calculators

http://deb.uthscsa.edu/URORiskCalc

The Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator (PCPTRC) Department of Urology at the University of Texas Health Science Center at San Antonio

http://sunnybrook.ca/content/?page=OCC_prostateCalc

The Sunnybrook Prostate Cancer Risk Calculator Edmonton Odette Cancer Center and Sunnybrook, University of Toronto

Nomogram

Nam RK, Toi A, Klotz LH, et al. Assessing individual risk for prostate cancer. J Clin Oncol 2007;25:3582–8.

Other tools

Multiparametric MRI

Obraz T2-zależny Obraz zależny od dyfuzji (DWI)

Dynamika przepływu kontrastu

Pozorny współczynnik dyfuzji (ADC map)

Spektroskopia MRI

New markers

• Shariat et al. found that the addition of a panel

• comprising pre-operative plasma levels of TGF- β 1,

• soluble IL-6R, IL-6, Endoglin, vascular endothelial

• growth factor (VEGF), and vascular cell adhesion

• molecule-1 (VCAM-1 or CD 106) [120,121,123,

• 133 – 137] impro ved the predictive accuracy the

• Kattan pre-operative nomogram [9] by 15.0% (i.e.

• 71.6 to 86.6%) [11,102]

https://www.google.pl/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=vxL7zJwQ2d4AEM&tbnid=3Q4G6nNN5MdNbM:&ved=0CAUQjRw&url=https://nowoczesnapolska.org.pl/2010/09/&ei=OgOaUc_tB4KOtQaaoIDQBA&bvm=bv.46751780,d.Yms&psig=AFQjCNEYf9ysl0BEJUzS565ZAV4J9ne4_A&ust=1369134196996635

PSA

http://www.google.pl/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=DnpVG_YD_ExQLM&tbnid=gyrdfNWxa2LhhM:&ved=0CAUQjRw&url=http://alexgraysonsquash.com/tournament-calendar/&ei=TFyRUYvrKNHwtQaim4CYDA&bvm=bv.46340616,d.Yms&psig=AFQjCNHpGoIqOl2cGKsdvw_BRkI36jEZmQ&ust=1368566787569755

Thank you !